International advisory board

The International Advisory Board (IAB) is comprised of 10 distinguished international and national members, representing a broad range of scientific expertise. The board plays a crucial role in overseeing and advising on the development of the BRIDGE - Translational Excellence Programme, ensuring that our research projects, fellows, and mentors consistently meet the highest international standards of excellence. The IAB operates under the guidance of the Programme Chair.

The board supervises the progress and quality of the programme, offering valuable guidelines and inspiration for its ongoing development.

In addition, the IAB plays a key role in guiding the programme towards its goal of training future translational investigators. By advising on strategic direction and providing a global perspective on advancements in translational science and innovative training methods, the IAB helps shape the future of translational research.

Members

IAB

Alan Moses (chair)

Former Global Chief Medical Officer and Professor Emeritus, Novo Nordisk A/S and Harvard University

Clare Balendran

Vice President of Precision Medicine, Biomarkers and Diagnostics, Novo Nordisk A/S

Kristian Helin

Professor, Chief Executive and President of The Institute of Cancer Research, London, and BRIC, University of Copenhagen

Marlys Koschinsky

Scientific and Executive Director and Professor, Robarts Research Institute and Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry

Peter Garred

Professor, Department of Clinical Immunology, Rigshospitalet and Department of Clinical Medicine, University of Copenhagen

Anthony Hollenberg

President, Boston Medical Center and Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine

Hans Bräuner

Professor, Vice-Dean for Research, Faculty of Health and Medical Sciences, University of Copenhagen

Malene Fischer

Deputy Chief Executive, Research Director, Rigshospitalet

Paul Conlin

Director, Professor and Chief of Medical Service, Clinical and Translational (C/T) Research Academy for Harvard Catalyst, Harvard Medical School, and VA Boston Healthcare System

Susan A. Slaugenhaupt

Professor, Harvard Medical School and Scientific Director, Mass General Research Institute, Massachusetts General Hospital